March 2027
Duavee
bazedoxifene acetate and estrogens, conjugated
Tablet (oral) · NDA 022247
Last listed protection ends
March 10, 2027
The FDA lists 1 patent for Duavee, and this is the day the last one ends. It is not the date a generic goes on sale.
Patents and exclusivities
- Patent 7,683,051Claims the drug substance, the drug product and a use (U-594, U-904)